Search Results | Neuro-Oncology | Oxford Academic

Skip to Main Content

1-20 of 68

Save search

Sort by

Sort Order Select

1

2 3 4

Next

Journal Article

PATH-52. DIFFERENCES IN GENE EXPRESSION, GENOME-WIDE METHYLATION AND METABOLITES IN ADULT DIFFUSE GLIOMAS

PDF

Anjali Vinocha and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii190–viii191, https://doi.org/10.1093/neuonc/noae165.0751

Published: 11 November 2024

Journal Article

PATH-51. CENTRAL NERVOUS SYSTEM METASTASES ARE GENOMICALLY DIVERGENT FROM THEIR RESPECTIVE EXTRACRANIAL SITES

PDF

David Huang and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii190, https://doi.org/10.1093/neuonc/noae165.0750

Published: 11 November 2024

Journal Article

PATH-37. A NEW SUBTYPE OF DIFFUSE MIDLINE GLIOMA, H3 K27 AND BRAF/FGFR1 CO-ALTERED, EXHIBITS SPECIFIC BIOLOGICAL CHARACTERISTICS AND NEW THERAPEUTIC VULNERABILITIES

PDF

Lucie Auffret and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii187, https://doi.org/10.1093/neuonc/noae165.0736

Published: 11 November 2024

Journal Article

PATH-33. THE IMPACT OF THE MOLECULAR CLASSIFICATION IN HISTOLOGICALLY DIAGNOSED GLIOBLASTOMAS

PDF

Yoshiki Arakawa and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii186, https://doi.org/10.1093/neuonc/noae165.0732

Published: 11 November 2024

Journal Article

PATH-32. THE PROGNOSTIC IMPACT OF CDKN2A/B HETEROZYGOUS DELETIONS IN IDH-MUTANT GLIOMA

PDF

Franziska Maria Ippen and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii185–viii186, https://doi.org/10.1093/neuonc/noae165.0731

Published: 11 November 2024

Journal Article

PATH-31. COMPLETE TUMOR DISAPPEARANCE ON BRAIN MRI AFTER STANDARD CHEMORADIATION THERAPY FOR A MOLECULAR GLIOBLASTOMA

PDF

Jeffrey Ahn and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii185, https://doi.org/10.1093/neuonc/noae165.0730

Published: 11 November 2024

Journal Article

PATH-30. CLINICAL OUTCOMES AND PREDICTIVE BIOMARKERS FOR IDH-WILDTYPE GLIOBLASTOMAS DEVELOPING HYPERMUTATION FOLLOWING TEMOZOLOMIDE TREATMENT

PDF

Jacob Young and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii185, https://doi.org/10.1093/neuonc/noae165.0729

Published: 11 November 2024

Journal Article

PATH-02. MESENCHYMAL-TYPE GENETIC MUTATIONS ARE LIKELY PRE-REQUISITE FOR GLIOBLASTOMA TO METASTASIZE OUTSIDE THE CENTRAL NERVOUS SYSTEM: AN ORIGINAL CASE SERIES AND SYSTEMATIC REVIEW OF THE LITERATURE

PDF

Bryce Laurin and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii177, https://doi.org/10.1093/neuonc/noae165.0701

Published: 11 November 2024

Journal Article

PATH-08. MOLECULAR DIVERGENCE RATES DIFFER BETWEEN BRAIN METASTASES AND EXTRACRANIAL DISEASE SITES ACROSS PRIMARY TUMOR HISTOLOGIES

PDF

Ramin Morshed and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii179, https://doi.org/10.1093/neuonc/noae165.0707

Published: 11 November 2024

Journal Article

PATH-07. CLINICAL AND RADIOGRAPHIC FEATURES OF DIFFUSE GLIOMA MOLECULAR SUBTYPES IN ACCORDANCE WITH THE 2021 CNS5 WHO CLASSIFICATION

PDF

Jasmin Jo and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii179, https://doi.org/10.1093/neuonc/noae165.0706

Published: 11 November 2024

Journal Article

PATH-21. SINGEL CELL TRANSCRIPTOMICS OF SPINAL EPENDYMOMA SUBTYPES IDENTIFIES INTRATUMORAL HETEROGENEITY

PDF

Karoline Hack and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii182, https://doi.org/10.1093/neuonc/noae165.0720

Published: 11 November 2024

Journal Article

PATH-19. DIAGNOSTIC UTILITY OF MOLECULAR PROFILING IN ADULT DIFFUSE GLIOMA

PDF

Makoto Ohno and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii182, https://doi.org/10.1093/neuonc/noae165.0718

Published: 11 November 2024

Journal Article

PATH-12. CLINICAL AND NEUROPATHOLOGICAL MARKERS FOR DISTINGUISHING BETWEEN IDH-MUTANT ASTROCYTOMAS OF WHO GRADE 2 AND 3

PDF

Jens Blobner and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii180, https://doi.org/10.1093/neuonc/noae165.0711

Published: 11 November 2024

Journal Article

PATH-11. TECTAL GLIOMA: CLINICAL, PATHOLOGICAL, AND MOLECULAR FEATURES

PDF

Ryoji Imoto and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii180, https://doi.org/10.1093/neuonc/noae165.0710

Published: 11 November 2024

Journal Article

PATH-66. MOLECULAR FEATURES RELATED TO LONG-TERM SURVIVAL IN GLIOBLASTOMA

PDF

Michal Nisnboym Ziv and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii194, https://doi.org/10.1093/neuonc/noae165.0765

Published: 11 November 2024

Journal Article

PATH-63. M6A REGULATOR-BASED MOLECULAR CLASSIFICATION AND HUB GENES ASSOCIATED WITH IMMUNE INFILTRATION CHARACTERISTICS AND CLINICAL OUTCOMES IN DIFFUSE GLIOMAS

PDF

Jie Lu and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii193, https://doi.org/10.1093/neuonc/noae165.0762

Published: 11 November 2024

Journal Article

PATH-61. GENOMIC SIGNATURE IN NON-SMALL CELL LUNG CANCER PATIENTS METASTATIC TO BRAIN-A SINGLE INSTITUTION EXPERIENCE

PDF

Maha Zafar and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii193, https://doi.org/10.1093/neuonc/noae165.0760

Published: 11 November 2024

Journal Article

PATH-58. SEQUENCING OF DNA RECOVERED FROM BRAIN TUMOR BIOPSY SURGICAL WASTE IMPROVES SENSITIVITY OF RAPID IDH/TP53-MUTANT TUMOR DIAGNOSES

PDF

Jack Wadden and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii192, https://doi.org/10.1093/neuonc/noae165.0757

Published: 11 November 2024

Journal Article

PATH-38. INTRACRANIAL SARCOMA WITH DICER1 MUTATION IN A PATIENT WITH NEUROFIBROMATOSIS TYPE 1

PDF

Allison Weisnicht and Nicholas Pytel

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii187, https://doi.org/10.1093/neuonc/noae165.0737

Published: 11 November 2024

Journal Article

PATH-36. DO GENE EXPRESSION PROFILES BETTER PREDICT OLIGODENDROGLIOMA SURVIVAL?

PDF

Vijaylaxmi Roy and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii186–viii187, https://doi.org/10.1093/neuonc/noae165.0735

Published: 11 November 2024

1

2 3 4

Next